Key Characteristics of Diet-Induced Obesity in C57BL/6 Mice

C57BL/6 mice are favored for diet-induced obesity studies because of their genetic predisposition for weight gain when fed a high-fat diet (HFD). They are well known for developing insulin resistance, making them ideal for studying type 2 diabetes, metabolic syndrome, and related complications. Additionally, their widespread use and genetic consistency enable reproducibility in obesity research.

Metabolic Changes	When subjected to high-fat diets, C57BL/6 mice exhibit significant metabolic changes, including hyperglycemia, hyperinsulinemia, and insulin resistance. These responses mimic the early stages of type 2 diabetes in humans.
Increased Adiposity	The C57BL/6 strain gains weight rapidly when fed HFD or high-caloric diets. Studies have shown that weight gain can be as high as 194% over 12 weeks on such diets, dramatically increasing adipose tissue mass.
Inflammatory Markers	DIO in C57BL/6 mice is also associated with systemic inflammation. Elevated levels of pro-inflammatory cytokines, such as TNF-alpha and IL-6, are observed, indicating that obesity leads to a chronic inflammatory state that exacerbates metabolic dysfunction.
Endothelial Dysfunction	Research has shown that DIO mice, such as C57BL/6 mice on high-fat diets, experience vascular complications due to endothelial dysfunction. This condition is characterized by reduced nitric oxide (NO) bioavailability and impaired vasodilation, contributing to cardiovascular risks.

Talk to an Expert

Comparing DIO Mice Models with Genetic Obesity Models

Unlike genetically induced models such as ob/ob or db/db mice, where obesity results from genetic mutations, diet-induced obesity models simulate obesity through dietary intake. This approach reflects human obesity more accurately, as lifestyle and diet are major contributors. C57BL/6 DIO mice, in particular, demonstrate a physiological response to high-calorie intake, providing a more realistic representation of human metabolic responses.

POSTER
Metabolic & Cardiovascular Disease Models
Explore the models available in your area and identify the one best suited to your study. Download the Poster

High-Fat Diet Protocol for Inducing Obesity in C57BL/6 Mice

To induce obesity, C57BL/6 mice are typically fed a high-fat diet (HFD) comprising 45 – 60% of calories from fat, significantly higher than standard rodent diets. Studies show that prolonged exposure to these diets leads to weight gain, adiposity, and metabolic impairments, making it an effective protocol for studying obesity and metabolic syndrome.

Importance of Diet Composition

Different dietary regimens significantly impact the results observed in C57BL/6 mice:

High-Fat Diets (HFD)	These diets typically consist of 45 – 60% energy from fat, which leads to rapid weight gain and early onset of metabolic disorders
Cafeteria Diets (CAF)	This approach includes a variety of palatable high-calorie foods and has been shown to induce obesity more effectively than standard high-fat diets

Do you need a custom diet? Learn how we can help.

sugar molecule with purple white red colors

Optimize Your Obesity Program
Our expertise in metabolic drug discovery, spanning from target identification and pharmacology to IND studies, makes us ideally suited to run your diet induced obesity studies for you.

Learn More

Research Applications for C57BL/6 DIO Mice

C57BL/6 DIO mice have been valuable in various research domains:

Metabolic Syndrome	These DIO mice develop metabolic syndrome symptoms, including insulin resistance, glucose intolerance, and dyslipidemia, making them useful for studying type 2 diabetes and cardiovascular diseases
Non-Alcoholic Fatty Liver Disease (NAFLD)	Their tendency to accumulate liver fat on a high-fat diet makes C57BL/6 DIO mice instrumental in researching NAFLD's progression and treatment
Pharmacological Testing	The DIO model helps evaluate anti-obesity drugs by assessing their effects on weight, insulin sensitivity, and lipid metabolism

Benefits of C57BL/6 DIO Mice for Metabolic Research

C57BL/6 DIO mice have been valuable in various research domains:

Genetic Consistency	As an inbred strain, C57BL/6 mice offer uniform genetics, which helps ensure reliable results across studies
Insulin Resistance Development	Under high-fat diet conditions, these mice naturally develop insulin resistance, closely mimicking human type 2 diabetes
Human Relevance	Given their metabolic response to diet, C57BL/6 mice serve as a realistic model for studying obesity-related conditions and aiding in developing treatments and interventions

Challenges with C57BL/6 DIO Mice in Research

The primary challenge in diet-induced obesity studies is animal variability in response to high-fat diets. Not all C57BL/6 mice respond uniformly; some develop more severe obesity and insulin resistance than others. Standardizing factors such as diet composition, age, and feeding duration can help mitigate these differences.

Best Practices for Maintaining C57BL/6 DIO Mice

To achieve reliable results, maintaining DIO mice requires a controlled diet and environment. High-fat feeding usually begins at 6 – 8 weeks and continues for at least 10 – 12 weeks to establish obesity. Consistent monitoring of parameters such as weight, food intake, and glucose tolerance is essential for tracking obesity progression and associated metabolic changes.

The Future of Obesity Research with C57BL/6 DIO Mice

With the rise in obesity-related diseases, the role of DIO C57BL/6 mice in research is increasingly critical. Advancements in genomics and metabolic profiling enhance our understanding of how high-fat diets interact with genetic factors in C57BL/6 mice, identifying new therapeutic targets for obesity and its associated comorbidities. These models are invaluable in guiding treatment development for obesity-related conditions in humans.